SI2350093T1 - Substituirani tetrahidrotienopiridini kotKCNQ modulatorji za zdravljenje bolečine epilepsije in urinske inkotinence - Google Patents

Substituirani tetrahidrotienopiridini kotKCNQ modulatorji za zdravljenje bolečine epilepsije in urinske inkotinence

Info

Publication number
SI2350093T1
SI2350093T1 SI200930353T SI200930353T SI2350093T1 SI 2350093 T1 SI2350093 T1 SI 2350093T1 SI 200930353 T SI200930353 T SI 200930353T SI 200930353 T SI200930353 T SI 200930353T SI 2350093 T1 SI2350093 T1 SI 2350093T1
Authority
SI
Slovenia
Prior art keywords
tetrahydrothienopyridines
kcnq2
epilepsy
modulators
substituted
Prior art date
Application number
SI200930353T
Other languages
English (en)
Inventor
Sven Kuhnert
Gregor Bahrenberg
Achim Kless
Beatrix Merla
Klaus Schiene
Wolfgang Schroder
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of SI2350093T1 publication Critical patent/SI2350093T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SI200930353T 2008-10-24 2009-10-22 Substituirani tetrahidrotienopiridini kotKCNQ modulatorji za zdravljenje bolečine epilepsije in urinske inkotinence SI2350093T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08018617 2008-10-24
PCT/EP2009/007567 WO2010046108A1 (de) 2008-10-24 2009-10-22 Substituierte 4,5,6,7-tetrahydrothienopyridine als kcnq2/3 modulatoren zur behandlung von schmerz, epilepsie und harninkontinenz
EP09747793A EP2350093B1 (de) 2008-10-24 2009-10-22 Substituierte 4,5,6,7-tetrahydrothienopyridine als kcnq2/3 modulatoren zur behandlung von schmerz, epilepsie und harninkontinenz

Publications (1)

Publication Number Publication Date
SI2350093T1 true SI2350093T1 (sl) 2012-11-30

Family

ID=40383750

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200930353T SI2350093T1 (sl) 2008-10-24 2009-10-22 Substituirani tetrahidrotienopiridini kotKCNQ modulatorji za zdravljenje bolečine epilepsije in urinske inkotinence

Country Status (15)

Country Link
US (1) US20100105722A1 (sl)
EP (1) EP2350093B1 (sl)
JP (1) JP2012506395A (sl)
AU (1) AU2009306722A1 (sl)
BR (1) BRPI0919898A2 (sl)
CA (1) CA2739740A1 (sl)
CY (1) CY1113373T1 (sl)
DK (1) DK2350093T3 (sl)
ES (1) ES2392758T3 (sl)
HR (1) HRP20120822T1 (sl)
MX (1) MX2011003849A (sl)
PL (1) PL2350093T3 (sl)
PT (1) PT2350093E (sl)
SI (1) SI2350093T1 (sl)
WO (1) WO2010046108A1 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201211007A (en) 2010-08-27 2012-03-16 Gruenenthal Gmbh Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators
US8653102B2 (en) 2010-08-27 2014-02-18 Gruenenthal Gmbh Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2/3 modulators
AR082734A1 (es) 2010-08-27 2012-12-26 Gruenenthal Gmbh Quinolino-3-carboxamidas sustituidas como moduladores de kcnq2/3
AU2011295405B2 (en) * 2010-08-27 2015-01-22 Grünenthal GmbH Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators
US8618129B2 (en) 2010-09-01 2013-12-31 Gruenenthal Gmbh Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators
US9168259B2 (en) 2010-10-20 2015-10-27 Grünenthal GmbH Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
MX367623B (es) 2010-10-20 2019-08-29 Gruenenthal Gmbh 6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3.
US9242994B2 (en) 2012-03-23 2016-01-26 Memorial Sloan-Kettering Cancer Center Treatment of pancreatic and related cancers with 5-acyl-6,7-dihydrothieno[3,2-c]pyridines
JP6033403B2 (ja) 2012-04-18 2016-11-30 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Ｋｃｎｑ２／３調節因子としてのｏｈ含有基を有する置換６−アミノ−ニコチンアミド類
MX2014012491A (es) 2012-04-18 2014-11-14 Grünenthal GmbH 4-aminobenzamidas sustituidas como moduladores de kcnq2/3.
WO2014082738A1 (en) 2012-11-28 2014-06-05 Grünenthal GmbH Heteroquinoline-3-carboxamides as kcnq2/3 modulators
US9248122B2 (en) 2012-11-28 2016-02-02 Grünenthal GmbH Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
AU2013351550A1 (en) 2012-11-28 2015-07-16 Grünenthal GmbH Specific carboxamides as KCNQ2/3 modulators
CA3180317A1 (en) 2020-04-17 2021-10-21 The Trustees Of Indiana University Small molecule antiviral drug treatment for human papillomavirus infections
US11931356B1 (en) 2022-11-30 2024-03-19 The Trustees Of Indiana University Compositions and methods for treating human papilloma virus infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733750B1 (fr) * 1995-05-03 1997-06-13 Synthelabo Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique
US6855829B2 (en) * 2001-02-20 2005-02-15 Bristol-Myers Squibb Company 3-fluoro-2-oxindole modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related disease
ES2309765T3 (es) * 2004-05-28 2008-12-16 4Sc Ag Tetrahidropiridotiofenos.
US7714134B2 (en) * 2004-06-11 2010-05-11 4Sc Ag Compounds and use of tetrahydropyridothiophenes
DE102006049452A1 (de) * 2006-10-17 2008-05-08 Grünenthal GmbH Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln
WO2009001128A1 (en) * 2007-06-26 2008-12-31 Astrazeneca Ab 1,2-cycl0hexane dicarboxamides as cathepsin inhibitors

Also Published As

Publication number Publication date
CA2739740A1 (en) 2010-04-29
JP2012506395A (ja) 2012-03-15
BRPI0919898A2 (pt) 2016-02-16
PT2350093E (pt) 2012-11-02
ES2392758T3 (es) 2012-12-13
DK2350093T3 (da) 2012-11-12
CY1113373T1 (el) 2016-06-22
EP2350093A1 (de) 2011-08-03
WO2010046108A1 (de) 2010-04-29
PL2350093T3 (pl) 2013-01-31
US20100105722A1 (en) 2010-04-29
MX2011003849A (es) 2011-05-23
AU2009306722A1 (en) 2010-04-29
HRP20120822T1 (hr) 2012-11-30
EP2350093B1 (de) 2012-10-03

Similar Documents

Publication Publication Date Title
SI2350093T1 (sl) Substituirani tetrahidrotienopiridini kotKCNQ modulatorji za zdravljenje bolečine epilepsije in urinske inkotinence
EP2173275A4 (en) APPARATUS AND METHOD FOR TREATING INCONTINENCE TO EFFORT
EP2346416A4 (en) METHOD AND DEVICES FOR TREATING SPINAL STENOSIS
IL202015A0 (en) Methods and compositions for treating skin conditions
EP2170309A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES
IL209032A0 (en) Compositions and methods for treating digestive disorders
EP2094180A4 (en) METHODS AND SYSTEMS FOR TREATING TISSUE SITES USING ELECTROCORPORATION
EP2260109A4 (en) METHODS AND COMPOSITIONS BASED ON MICRO-RNA FOR DIAGNOSING, PROGNOSING AND TREATING PROSTATE-RELATED DISORDERS
EP2088952A4 (en) METHODS AND DEVICES FOR PROCESSING FABRICS
EP2229171A4 (en) METHOD AND COMPOSITIONS FOR TREATING POST-OPERATIVE PAIN WITH A LOCAL ANESTHETIC
EP2073752A4 (en) IMPLANTABLE DEVICES FOR THE TREATMENT OF INCONTINENCE, AND METHODS OF USE
ZA200902213B (en) Urinary incontinence device applicator
HK1162366A1 (en) Devices and methods for treating and or preventing diseases
ZA201006293B (en) Composition and method for seed treatment use
GB0718523D0 (en) Agricultural treatment
IL202424A (en) Telomerase activator compounds for use in the treatment of disorders and related conditions
PL2106774T3 (pl) Regulowany aplikator dla urządzeń stosowanych przy nietrzymaniu moczu
HK1245679A1 (zh) 用於治療皮膚疾病和病症的方法和組合物
EP2272472A4 (en) Excrement treating apparatus
HK1232162A1 (zh) 治療疼痛症狀及其它失調的化合物
EP2051727A4 (en) METHOD FOR THE TREATMENT OF FIBROTIC DISEASES AND KELOIDS
HK1139856A1 (en) Methods for treating acute pain
IL193697A0 (en) Methods for treating cognitive and other disorders
EP2300042A4 (en) COMPOSITIONS AND METHODS FOR TREATING URINARY INCONTINENCE
IL213120A0 (en) Method for treating parkinson' s disease